Orbital Therapeutics IPO

orbitaltx.com

Orbital Therapeutics strives to provide health solutions through the use of RNA-based treatments and medicines.

Founded2022
Total Funding to Date$103MM
Register for Details

For more details on financing and valuation for Orbital Therapeutics, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Orbital Therapeutics Ticker Symbol

Orbital Therapeutics does not currently have an official ticker symbol because this company is still private. Register today to connect with our Private Market Specialists and learn more about new pre-IPO investment opportunities.

Orbital Therapeutics Stock Price

The stock price for Orbital Therapeutics will be known as it becomes public. Here are similar public companies: HealthStream (NAS: HSTM), Doximity (NYS: DOCS), Zymergen (NAS: ZY), Sight Sciences (NAS: SGHT).

Orbital Therapeutics Funding Rounds and IPO Valuation

Date Funding Round Funding Raised Price per Share IPO Valuation
9/7/2022 Series Seed $103MM raised $XXX.XX $XXX.XX
Based on primary financings
Powered by Forge Data

Other companies like Orbital Therapeutics in the Healthcare sector

Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$3.67B
Sector
 
 
Sector
Last Round Est. Valuation
$317.32MM
Sector
Last Round Est. Valuation
$334.19MM
Sector
Last Round Est. Valuation
$1.08B
Sector
Last Round Est. Valuation
$1.59B
Sector
Last Round Est. Valuation
$4.26B
Sector